Phytonix Corp. is prototype stage. Our proprietary IP uses synthetic biology to create biosafe n-butanol and pentanol secreting microbial factories w/ carbon dioxide as the sole feedstock & oxygen as the byproduct. Our distributed, capital-light business model achieves breakthrough results with world-class scientific partners. Current market size is $9 B. Our process is highly carbon-negative, displacing a fossil-based, carbon-intensive process.